Elisa Sassetti

Dr. Elisa Sassetti

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2018 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
CMCarlos Moreno-Cinos
Carlos Moreno-Cinos
ESElisa Sassetti
Elisa Sassetti
ISIrene G. Salado
Irene G. Salado
GWGesa Witt
Gesa Witt
SBSiham Benramdane
Siham Benramdane
KAKoen Augustyns
Koen Augustyns

Verified
Journal Article
Open access
PDF file
ESElisa Sassetti
Elisa Sassetti
CCCristina Durante Cruz
Cristina Durante Cruz
PTPäivi Tammela
Päivi Tammela
MWMathias Winterhalter
Mathias Winterhalter
KAKoen Augustyns
Koen Augustyns
Björn WindshügelBjörn Windshügel
Björn Windshügel
The serine protease Caseinolytic protease subunit P (ClpP) plays an important role for protein homeostasis in bacteria and contributes to various developmental processes, as well as virulence. Therefore, ClpP is considered as a potential drug target in Gram-positive and Gram-negative bacteria. In this study, we utilized a biochemical assay to screen several small molecule libraries of approved and investigational drugs for Escherichia coli ClpP inhibitors. The approved drugs bortezomib, cefmetazole, cisplatin, as well as the investigational drug cDPCP, and the protease inhibitor 3,4-dichloroisocoumarin (3,4-DIC) emerged as ClpP inhibitors with IC50 values ranging between 0.04 and 31 µM. Compound profiling of the inhibitors revealed cefmetazole and cisplatin not to inhibit the serine protease bovine α-chymotrypsin, and for cefmetazole no cytotoxicity against three human cell lines was detected. Surface plasmon resonance studies demonstrated all novel ClpP inhibitors to bind covalently to ClpP. Investigation of the potential binding mode for cefmetazole using molecular docking suggested a dual covalent binding to Ser97 and Thr168. While only the antibiotic cefmetazole demonstrated an intrinsic antibacterial effect, cDPCP clearly delayed the bacterial growth recovery time upon chemically induced nitric oxide stress in a ClpP-dependent manner.

7 February 2023 in ChemBioChem
Verified
Journal Article
Open access
TWThomas Whitmarsh‐Everiss
Thomas Whitmarsh‐Everiss
ZWZhou Wang
Zhou Wang
CHCecilie Hauberg Hansen
Cecilie Hauberg Hansen
LDLaura Depta
Laura Depta
ESElisa Sassetti
Elisa Sassetti
LLLuca Laraia
Luca Laraia
Combining natural product fragments to design new scaffolds with unprecedented bioactivity is a powerful strategy for the discovery of tool compounds and potential therapeutics. However, the choice of fragments to couple and the biological screens to employ remain open questions in the field. By choosing a primary fragment containing the A/B ring system of estradiol and fusing it to nine different secondary fragments, we were able to identify compounds that modulated four different phenotypes: inhibition of autophagy and osteoblast differentiation, as well as potassium channel and tubulin modulation. The latter two were uncovered by using unbiased morphological profiling with a cell‐painting assay. The number of hits and variety in bioactivity discovered validates the use of recombining natural product fragments coupled to phenotypic screening for the rapid identification of biologically diverse compounds.